Deutsche Bank’s China Pharma Holdings CPHI Stock Holding History

Deutsche Bank’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13	Closed	-$1K	–	4402
2019 Q4	$1K	Buy	+13	New	+$1.6K	﹤0.01%	4902
2019 Q3	–	Sell	-149	Closed	-$24K	–	4938
2019 Q2	$24K	Sell	149 -281	-65%	-$45.1K	﹤0.01%	4751
2019 Q1	$71K	Buy	+430	New	+$63.3K	﹤0.01%	4439

Other funds holding CPHI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank's CPHI Position: Q1 2020 in Review

Deutsche Bank sold out of China Pharma Holdings (CPHI) in Q1 2020, closing a stake of 13 shares — an estimated $1K sold.

Deutsche Bank first reported a position in CPHI in Q1 2019 and held it in 3 quarters. The position peaked at $71K in Q1 2019. 3 funds tracked by Wall St. Rank hold CPHI as of Q1 2020.

Deutsche Bank reported no remaining China Pharma Holdings position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 13 China Pharma Holdings shares in Q1 2020, an estimated $1K.
Deutsche Bank first reported a position in China Pharma Holdings in Q1 2019 and held it in 3 quarters.
Deutsche Bank's China Pharma Holdings position peaked at $71K in Q1 2019.
3 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.